| 标题： | 儿童血栓性疾病药学实践专家共识 |
| title： | Expert consensus on pharmaceutical practice of children's thrombotic disease |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 治疗 |
| field： | Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 医学、临床药学 |
| Guide users： | Medicine and clinical pharmacy |
| 证据分级方法： | GRADE分级系统（Grades of Recommendation，Assessment，Development and Evaluation，GRADE） |
| Evidence grading method： | GRADE classification system |
| 制定单位： | 中华医学会临床药学分会；四川省医学科学院&四川省人民医院 |
| Formulating unit： | Clinical Pharmacy Branch of Chinese Medical Association；Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital |
| 注册时间： | 2022-11-21 |
| Registration time： | |
| 注册编号： | PREPARE-2022CN758 |
| Registration number： | |
| 指南制订的目的： | 互联网和数字化时代，科技文献量与日俱增，科研成果的增多和学者精力的有限，局限了对国内外儿童血栓性疾病药物治疗研究成果的全景扫描，从而无法全面了解国内外的研究情况，以定量化、大范围数据分析已经无法满足学者对更广泛研究成果的考察需求。 本专家共识的研究价值在于：在理论上建立了PICO以及数据库的检索策略，为数据采集提供理论与方法指导，构建了儿童血栓性疾病抗栓治疗的推荐分级，以期为儿童抗栓治疗提供不同层面方法与过程参考。在实际应用上：进行了儿童血栓性疾病抗栓治疗国内外比较分析以及汇总，有助于发现我国与国外抗栓治疗发展中的差异、差距，从而为我国抗栓治疗研究与实践提供数据支持。基于此为医生、药师合理选用抗栓药物提供理论支持和循证证据。 |
| Purpose of the guideline： | In the Internet and digital era, the growing volume of scientific and technological literature, the increase of scientific research achievements and the limited energy of scholars have limited the panoramic scanning of domestic and foreign research achievements in the drug treatment of children's thrombotic diseases, which makes it impossible to fully understand domestic and foreign research. Quantitative and large-scale data analysis has been unable to meet the needs of scholars to investigate more extensive research achievements. The research value of this expert consensus lies in: theoretically establishing the retrieval strategy of PICO and database, providing theoretical and methodological guidance for data collection, and constructing the recommended classification of antithrombotic therapy for children's thrombotic diseases, with a view to providing different levels of methods and process reference for children's antithrombotic therapy. In practical application, the comparative analysis and summary of antithrombotic therapy for children's thrombotic diseases at home and abroad were carried out, which is helpful to find the differences and gaps in the development of antithrombotic therapy between China and foreign countries, thus providing data support for the research and practice of antithrombotic therapy in China. Based on this, it provides theoretical support and evidence-based evidence for doctors and pharmacists to reasonably select antithrombotic drugs. |
